We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > genetic diseases

News List

Pfizer partners with Beam Therapeutics to develop rare disease therapies ExpressPharma
January 11, 2022
Pfizer will collaborate with Beam Therapeutics in a deal worth as much as $1.35 billion to develop therapies for rare genetic diseases.
Deep Genomics raises $180m to advance drugs for genetic diseases pharmaceutical-technology
July 30, 2021
Deep Genomics has secured $180m in Series C funding round to advance its artificial intelligence (AI)-discovered drug programmes for genetic diseases into the clinic.
BridgeBio Pharma raises $299m to support drug R&D pharmaceutical-technology
January 25, 2019
US-based biopharmaceutical firm BridgeBio Pharma has raised $299.2m in a new financing round led by its existing investors KKR and Viking Global Investors.....